¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : À¯Çüº°, Á¦Ç° ¹× ¼ºñ½ºº°, ¾à¹° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå
:
1463133
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 119 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, °Ëü Ÿ´ç¼º ½ÃÇè ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 25¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¼¼°è ¼öÁØÀÇ ³²¿ë °Ë»ç ¿ä±¸ Áõ°¡´Â ½Ã·á Ÿ´ç¼º ½ÃÇè ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ëü Ÿ´ç¼º ½ÃÇèÀ¸·Î °³ÀÎÀÇ ¾à¹° ¼·Ãë ¹× ±âŸ À½½Ä ¼·Ã븦 È®ÀÎÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀÌ ¹ý·üÀ̳ª ¹ýÀÇÇРȰµ¿¿¡¼ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °ËüÀÇ º¯Á¶°¡ ÇöÀúÇÏ°Ô Áõ°¡ÇÏ°í ¼Òº¯ °ËüÀÇ º¸¾È°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ °Ëü Ÿ´ç¼º ½ÃÇè µµ±¸·Î °ËüÀÇ ¹«°á¼ºÀ» È®ÀÎÇÏ´Â °ÍÀÌ ¹ý ÁýÇà°ü¿¡°Ô Àå·ÁµÇ°í ÀÖ½À´Ï´Ù.
ºÒ¼ø¹° ¿À¿°, Èñ¼®, º¯Á¶¸¦ °áÁ¤ÇÏ´Â ±â´ÉÀº Á÷Àå, ¾à¹° °Ë»ç, Çü»ç »ç¹ý ½Ã½ºÅÛ ¹× ¼¼°è ½ÃÀåÀÇ ´Ù¸¥ ºÎ¹®¿¡¼ äÅÃµÈ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ºÎÁ¤È®ÇÑ ¾à¹° °Ë»ç °á°ú´Â ¸¹Àº »ç¶÷µé¿¡°Ô ÇØ¸¦ ³¢Ä¥ ¼ö Àֱ⠶§¹®¿¡ ¾à¹° °Ë»çÀÇ ½Å·Ú¼ºÀ» °áÁ¤Çϱâ À§ÇÑ ÀÇÇÐÀû °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
°Ëü Ÿ´ç¼º ½ÃÇèÀº Ç×°ø±â, öµµ, ÀÚµ¿Â÷ ¿î¼Û¾÷ÀÚ ¹× ±âŸ ¼ö¼Û°ú °°Àº ±ÔÁ¦µÈ ºÎ¼ÀÇ ¹Ì¹¦ÇÑ Àå¼Ò¿¡ ÀÖ´Â °³Àο¡ ´ëÇØ ³Î¸® ½Ç½ÃµË´Ï´Ù. ±¹¹ÎÀÇ ¾ÈÀüÀ» º¸È£Çϱâ À§ÇØ È¿°úÀûÀÎ ¾à¹° °Ë»ç µµ±¸¸¦ äÅÃÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, ±³ÅëºÎ(DOT)´Â ¼Òº¯ °Ë»ç¸¦ ´ëüÇϱâ À§ÇØ °æ±¸ ¾à¹° °Ë»ç¸¦ µµÀÔÇß½À´Ï´Ù.
Á÷Àå°ú ¿î¼Û¿¡ ÀÖ¾î¼ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ ¼¼°èÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â ½Ã·áÀÇ À¯È¿¼º °Ë»ç¿¡ ´Ù¾çÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡, ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â ÇÕ¼º ¼Òº¯À» °áÁ¤ÇÏ°í »õ·Î¿î °Ëü Ÿ´ç¼º ½ÃÇèÀ» âÃâÇϱâ À§ÇÑ ÀáÀçÀû ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, WILEY ÀâÁö¿¡ °ÔÀçµÈ 2023³â ¿¬±¸¿¡¼´Â ½Ã·á Á¶ÀÛ °Ë»ç¿¡ ´ëÇÑ °ËÅä°¡ ÀÌ·ç¾îÁ³½À´Ï´Ù.
½Ã·á À¯È¿¼º ½ÃÇè ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
¼Òº¯ °Ë»ç ¼ºñ½º¸¦ Á¦°øÇÏ´Â ½ÇÇè½Ç ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó °Ë»ç½Ç °Ë»ç ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
Á¦Ç° ºÎ¹®Àº ¼Òº¯ °Ë»ç Ȱµ¿ÀÇ Áö¼ÓÀûÀÎ ¿ä±¸¿¡ µû¶ó °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.
Ç×¹ÙÀÌ·¯½ºÁ¦¹° ºÎ¹®Àº ¹ÙÀÌ·¯½º °¨¿°ÀÇ À¯ÇàÀ¸·Î ÀÎÇØ ´õ Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼´Â ¾à¹° ½ºÅ©¸®´× °Ë»çÀÇ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå ÀλçÀÌÆ®
°Ëü Ÿ´ç¼º ½ÃÇè - ¾÷°è ½º³À¼¦
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¾à¹° »ç¿ëÀ» ¿ÏÈÇϱâ À§ÇÑ Á¤ºÎ ±ÔÁ¦ °È
ºÒ¹ý ¾à¹°ÀÇ »ç¿ë Áõ°¡
¾ïÁ¦¿äÀΰú °úÁ¦
´ëü ¾à¹° ½ºÅ©¸®´× °Ë»ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡
PESTLE ºÐ¼®
°Ëü Ÿ´ç¼º ½ÃÇè ¾÷°è µ¿Çâ
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
ÀÓ»ó °Ë»ç
½Å¼Ó/POC Å×½ºÆ®
Á¦6Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
Ç÷·ù °¨¿°Áõ
¿ä·Î °¨¿°Áõ
¼ö¼ú ºÎÀ§ °¨¿°
Æó·Å
±âŸ
Á¦7Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
Á¦Ç°
¼ºñ½º
Á¦8Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
Ç×±ÕÁ¦
Ç×Áø±ÕÁ¦
Ç×¹ÙÀÌ·¯½ºÁ¦
±âŸ
Á¦9Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
¾à¹° ½ºÅ©¸®´× ¿¬±¸¼Ò
ÅëÁõ °ü¸® ¼¾ÅÍ
¾à¹° ÀçȰ¼¾ÅÍ
Á÷Àå
±âŸ
Á¦10Àå ¼¼°èÀÇ °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼Ò°³
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå Æò°¡, Áö¿ª(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°(2019-2032³â)
ºÏ¹Ì : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°(2019-2032³â)
ºÏ¹Ì : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°(2019-2032³â)
ºÏ¹Ì : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°(2019-2032³â)
ºÏ¹Ì : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¹Ì±¹
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ij³ª´Ù
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - À¯·´
À¯·´ : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°(2019-2032³â)
À¯·´ : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°(2019-2032³â)
À¯·´ : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°(2019-2032³â)
À¯·´ : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°(2019-2032³â)
À¯·´ : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¿µ±¹
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ÇÁ¶û½º
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - µ¶ÀÏ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ÀÌÅ»¸®¾Æ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ½ºÆäÀÎ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ³×´ú¶õµå
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ·¯½Ã¾Æ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°(2019-2032³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Áß±¹
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Àεµ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ÀϺ»
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¸»·¹À̽þÆ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Àεµ³×½Ã¾Æ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Çѱ¹
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°(2019-2032³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - UAE
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - À̽º¶ó¿¤
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, À¯Çüº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ¾àÁ¦ À¯Çüº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÀûÀÀÁõº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, Á¦Ç° ¹× ¼ºñ½ºº°(2019-2032³â)
¶óƾ¾Æ¸Þ¸®Ä« : °Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2032³â)
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¸ß½ÃÄÚ
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ºê¶óÁú
°Ëü Ÿ´ç¼º ½ÃÇè ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦11Àå °æÀï ±¸µµ
È®´ë¿Í Àμö ºÐ¼®
ÆÄÆ®³Ê½Ê/Çù¾÷/°è¾à/°ø°³
Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
Abbott(US)
Alfa Scientific Designs(US)
Healgen Scientific LLC(US)
LabCorp(US)
Nona Scientific Laboratory(US)
Omega Laboratories(Canada)
Premier Biotech, Inc.(US)
Quest Diagnostics(US)
Rochester Regional Health(US)
Sciteck, Inc.(US)
Siemens Healthineers(Germany)
Thermo Fisher Scientific(US)
Vision Diagnostics, Inc.(India)
JHS
¿µ¹® ¸ñÂ÷
The global specimen validity testing market size is expected to reach USD 2.52 billion by 2032, according to a new study by Polaris Market Research. The report "Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising need for abuse testing at the global level highly drives the growth of the specimen validity testing market. The potential to identify the individual's drug intake and other food intake with specimen validity testing is facilitating its adoption in legal and forensic science activities. The significant rise in sample tampering and growing concerns about the security and safety of urine samples encouraged legal officers to check the integrity of the sample with specimen validity testing tools.
The capability to determine adulteration, dilution, and tampering is the primary factor contributing to its adoption in the workplace, drug testing, criminal justice system, and other sectors of the global marketplace. As incorrect drug test results can cause harm to several people, there is increasing demand for medical tests to determine the reliability of the drug tests.
Specimen validity testing is widely conducted on individuals in sensitive places in the regulated sector, such as airplanes, rail, motor carriers, and other transits. The government's initiatives to adopt effective drug testing tools to safeguard the population are likely to propel market growth. For instance, in May 2023, the Department of Transportation (DOT) introduced oral drug testing as an alternative to urine testing.
Stringent regulations globally to improve safety at the workplace and in transportation are anticipated to create diverse opportunities for specimen validity testing. Furthermore, ongoing research studies are exploring potential technologies to determine synthetic urine and create new specimen validity testing. For instance, a 2023 study published in WILEY magazine conducted a review on sample manipulation testing.
Specimen Validity Testing Market Report Highlights
The laboratory testing segment is anticipated to witness the highest growth due to the growing number of laboratories providing urine testing services.
The products segment accounted for the largest market share owing to the continuous need for urine testing activities.
The antiviral drugs segment is projected to experience a larger revenue share due to the prevalence of viral infections.
Asia Pacific is projected to register the fastest growth during the forecast period due to the rising number of drug screening tests in the region.
The global players include Abbott, Alfa Scientific Designs, Healgen Scientific, LabCorp, Nona Scientific Laboratory, Omega Laboratories, & Premier Biotech.
Polaris Market Research has segmented the specimen validity testing market report based on product & service, type, drug type, indication, end user and region:
Specimen Validity Testing, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Laboratory Testing
Rapid/POC Testing
Specimen Validity Testing, Product & Service Outlook (Revenue - USD Billion, 2019 - 2032)
Products
Assay Kits
Reagents and Calibrators
Disposables
Services
Specimen Validity Testing, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Others
Specimen Validity Testing, Indication Outlook (Revenue - USD Billion, 2019 - 2032)
Bloodstream Infections
Urinary Tract Infections
Surgical Site Infections
Pneumonia
Others
Specimen Validity Testing, End User Outlook (Revenue - USD Billion, 2019 - 2032)
Drug Screening Laboratories
Pain Management Centers
Drug Rehabilitation Centre
Workplace
Others
Specimen Validity Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Specimen Validity Testing Market Insights
4.1. Specimen Validity Testing - Industry Snapshot
4.2. Specimen Validity Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising government regulations to mitigate drug use
4.2.1.2. Increased use of illegal drugs
4.2.2. Restraints and Challenges
4.2.2.1. Growing awareness about the alternative drug screening tests
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Specimen Validity Testing Industry Trends
4.6. COVID-19 Impact Analysis
5. Global Specimen Validity Testing Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
5.3. Laboratory Testing
5.3.1. Global Specimen Validity Testing Market, by Laboratory Testing, by Region, 2019-2032 (USD Billion)
5.4. Rapid/POC Testing
5.4.1. Global Specimen Validity Testing Market, by Rapid/POC Testing, by Region, 2019-2032 (USD Billion)
6. Global Specimen Validity Testing Market, by Indication
6.1. Key Findings
6.2. Introduction
6.2.1. Global Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
6.3. Bloodstream Infections
6.3.1. Global Specimen Validity Testing Market, by Bloodstream Infections, by Region, 2019-2032 (USD Billion)
6.4. Urinary Tract Infections
6.4.1. Global Specimen Validity Testing Market, by Urinary Tract Infections, by Region, 2019-2032 (USD Billion)
6.5. Surgical Site Infections
6.5.1. Global Specimen Validity Testing Market, by Surgical Site Infections, by Region, 2019-2032 (USD Billion)
6.6. Pneumonia
6.6.1. Global Specimen Validity Testing Market, by Pneumonia, by Region, 2019-2032 (USD Billion)
6.7. Others
6.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Specimen Validity Testing Market, by Product & Services
7.1. Key Findings
7.2. Introduction
7.2.1. Global Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
7.3. Products
7.3.1. Global Specimen Validity Testing Market, by Products, by Region, 2019-2032 (USD Billion)
7.3.2. Assay Kits
7.3.2.1. Global Specimen Validity Testing Market, by Assay Kits, by Region, 2019-2032 (USD Billion)
7.3.3. Reagents and Calibrators
7.3.3.1. Global Specimen Validity Testing Market, by Reagents and Calibrators, by Region, 2019-2032 (USD Billion)
7.3.4. Disposables
7.3.4.1. Global Specimen Validity Testing Market, by Disposables, by Region, 2019-2032 (USD Billion)
7.4. Services
7.4.1. Global Specimen Validity Testing Market, by Services, by Region, 2019-2032 (USD Billion)
8. Global Specimen Validity Testing Market, by Drug Type
8.1. Key Findings
8.2. Introduction
8.2.1. Global Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
8.3. Antibacterial Drugs
8.3.1. Global Specimen Validity Testing Market, by Antibacterial Drugs, by Region, 2019-2032 (USD Billion)
8.4. Antifungal Drugs
8.4.1. Global Specimen Validity Testing Market, by Antifungal Drugs, by Region, 2019-2032 (USD Billion)
8.5. Antiviral Drugs
8.5.1. Global Specimen Validity Testing Market, by Antiviral Drugs, by Region, 2019-2032 (USD Billion)
8.6. Others
8.6.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Specimen Validity Testing Market, by End-User
9.1. Key Findings
9.2. Introduction
9.2.1. Global Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
9.3. Drug Screening Laboratories
9.3.1. Global Specimen Validity Testing Market, by Drug Screening Laboratories, by Region, 2019-2032 (USD Billion)
9.4. Pain Management Centers
9.4.1. Global Specimen Validity Testing Market, by Pain Management Centers, by Region, 2019-2032 (USD Billion)
9.5. Drug Rehabilitation Centre
9.5.1. Global Specimen Validity Testing Market, by Drug Rehabilitation Centre, by Region, 2019-2032 (USD Billion)
9.6. Workplace
9.6.1. Global Specimen Validity Testing Market, by Workplace, by Region, 2019-2032 (USD Billion)
9.7. Others
9.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
10. Global Specimen Validity Testing Market, by Geography
10.1. Key findings
10.2. Introduction
10.2.1. Specimen Validity Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
10.3. Specimen Validity Testing Market - North America
10.3.1. North America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.3.2. North America: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.3.3. North America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.3.4. North America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.3.5. North America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.3.6. Specimen Validity Testing Market - U.S.
10.3.6.1. U.S.: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.3.6.2. U.S.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.3.6.3. U.S.: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.3.6.4. U.S.: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.3.6.5. U.S.: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.3.7. Specimen Validity Testing Market - Canada
10.3.7.1. Canada: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.3.7.2. Canada.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.3.7.3. Canada: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.3.7.4. Canada: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.3.7.5. Canada: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4. Specimen Validity Testing Market - Europe
10.4.1. Europe: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.2. Europe.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.3. Europe: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.4. Europe: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.5. Europe: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.6. Specimen Validity Testing Market - UK
10.4.6.1. UK: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.6.2. UK.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.6.3. UK: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.6.4. UK: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.6.5. UK: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.7. Specimen Validity Testing Market - France
10.4.7.1. France: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.7.2. France.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.7.3. France: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.7.4. France: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.7.5. France: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.8. Specimen Validity Testing Market - Germany
10.4.8.1. Germany: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.8.2. Germany.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.8.3. Germany: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.8.4. Germany: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.8.5. Germany: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.9. Specimen Validity Testing Market - Italy
10.4.9.1. Italy: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.9.2. Italy.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.9.3. Italy: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.9.4. Italy: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.9.5. Italy: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.10. Specimen Validity Testing Market - Spain
10.4.10.1. Spain: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.10.2. Spain.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.10.3. Spain: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.10.4. Spain: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.10.5. Spain: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.11. Specimen Validity Testing Market - Netherlands
10.4.11.1. Netherlands: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.11.2. Netherlands.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.11.3. Netherlands: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.11.4. Netherlands: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.11.5. Netherlands: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.4.12. Specimen Validity Testing Market - Russia
10.4.12.1. Russia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.4.12.2. Russia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.4.12.3. Russia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.4.12.4. Russia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.4.12.5. Russia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5. Specimen Validity Testing Market - Asia Pacific
10.5.1. Asia Pacific: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.2. Asia Pacific.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.3. Asia Pacific: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.4. Asia Pacific: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.5. Asia Pacific: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.6. Specimen Validity Testing Market - China
10.5.6.1. China: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.6.2. China.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.6.3. China: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.6.4. China: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.6.5. China: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.7. Specimen Validity Testing Market - India
10.5.7.1. India: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.7.2. India.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.7.3. India: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.7.4. India: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.7.5. India: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.8. Specimen Validity Testing Market - Japan
10.5.8.1. Japan: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.8.2. Japan.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.8.3. Japan: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.8.4. Japan: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.8.5. Japan: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.9. Specimen Validity Testing Market - Malaysia
10.5.9.1. Malaysia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.9.2. Malaysia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.9.3. Malaysia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.9.4. Malaysia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.9.5. Malaysia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.10. Specimen Validity Testing Market - Indonesia
10.5.10.1. Indonesia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.10.2. Indonesia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.10.3. Indonesia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.10.4. Indonesia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.10.5. Indonesia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.5.11. Specimen Validity Testing Market - South Korea
10.5.11.1. South Korea: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.5.11.2. South Korea.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.5.11.3. South Korea: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.5.11.4. South Korea: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.5.11.5. South Korea: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.6. Specimen Validity Testing Market - Middle East & Africa
10.6.1. Middle East & Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.6.2. Middle East & Africa: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.6.3. Middle East & Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.6.4. Middle East & Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.6.5. Middle East & Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.6.6. Specimen Validity Testing Market - Saudi Arabia
10.6.6.1. Saudi Arabia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.6.6.2. Saudi Arabia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.6.6.3. Saudi Arabia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.6.6.4. Saudi Arabia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.6.6.5. Saudi Arabia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.6.7. Specimen Validity Testing Market - UAE
10.6.7.1. UAE: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.6.7.2. UAE.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.6.7.3. UAE: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.6.7.4. UAE: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.6.7.5. UAE: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.6.8. Specimen Validity Testing Market - Israel
10.6.8.1. Israel: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.6.8.2. Israel.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.6.8.3. Israel: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.6.8.4. Israel: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.6.8.5. Israel: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.6.9. Specimen Validity Testing Market - South Africa
10.6.9.1. South Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.6.9.2. South Africa.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.6.9.3. South Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.6.9.4. South Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.6.9.5. South Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.7. Specimen Validity Testing Market - Latin America
10.7.1. Latin America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.7.2. Latin America.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.7.3. Latin America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.7.4. Latin America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.7.5. Latin America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.7.6. Specimen Validity Testing Market - Mexico
10.7.6.1. Mexico: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.7.6.2. Mexico.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.7.6.3. Mexico: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.7.6.4. Mexico: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.7.6.5. Mexico: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.7.7. Specimen Validity Testing Market - Brazil
10.7.7.1. Brazil: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.7.7.2. Brazil.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.7.7.3. Brazil: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.7.7.4. Brazil: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.7.7.5. Brazil: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
10.7.8. Specimen Validity Testing Market - Argentina
10.7.8.1. Argentina: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
10.7.8.2. Argentina.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
10.7.8.3. Argentina: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
10.7.8.4. Argentina: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
10.7.8.5. Argentina: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
11. Competitive Landscape
11.1. Expansion and Acquisition Analysis
11.1.1. Expansion
11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
12.1. Abbott (US)
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Recent Development
12.2. Alfa Scientific Designs (US)
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Benchmarking
12.2.4. Recent Development
12.3. Healgen Scientific LLC (US)
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Benchmarking
12.3.4. Recent Development
12.4. LabCorp (US)
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Benchmarking
12.4.4. Recent Development
12.5. Nona Scientific Laboratory (US)
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Benchmarking
12.5.4. Recent Development
12.6. Omega Laboratories (Canada)
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Benchmarking
12.6.4. Recent Development
12.7. Premier Biotech, Inc. (US)
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Benchmarking
12.7.4. Recent Development
12.8. Quest Diagnostics (US)
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Benchmarking
12.8.4. Recent Development
12.9. Rochester Regional Health (US)
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Benchmarking
12.9.4. Recent Development
12.10. Sciteck, Inc. (US)
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Benchmarking
12.10.4. Recent Development
12.11. Siemens Healthineers (Germany)
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Benchmarking
12.11.4. Recent Development
12.12. Thermo Fisher Scientific (US)
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Benchmarking
12.12.4. Recent Development
12.13. Vision Diagnostics, Inc. (India)
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Benchmarking
12.13.4. Recent Development
°ü·ÃÀÚ·á